Detalhe da pesquisa
1.
Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease.
Ann Neurol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767012
2.
Parkinson's disease and vitamins: a focus on vitamin B12.
J Neural Transm (Vienna)
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38602571
3.
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson's Disease.
J Neuropsychiatry Clin Neurosci
; 35(3): 236-243, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710627
4.
Revisiting Alpha-Synuclein Pathways to Inflammation.
Int J Mol Sci
; 24(8)2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37108299
5.
Factor Analysis and Clustering of the Movement Disorder Society-Non-Motor Rating Scale.
Mov Disord
; 35(6): 969-975, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32220114
6.
Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson's disease.
BMC Neurosci
; 20(1): 55, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31640554
7.
Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease.
Mov Disord
; 31(3): 270-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695691
8.
New clinical trials for nonmotor manifestations of Parkinson's disease.
Mov Disord
; 30(11): 1490-504, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26371623
9.
Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study.
BMC Neurol
; 14: 42, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24602411
10.
Perceptions of symptoms and expectations of advanced therapy for Parkinson's disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson's disease (PRO-APD).
Health Qual Life Outcomes
; 12: 11, 2014 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24460704
11.
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert Panel.
J Parkinsons Dis
; 14(1): 53-63, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38217610
12.
A scoping review of neurodegenerative manifestations in explainable digital phenotyping.
NPJ Parkinsons Dis
; 9(1): 49, 2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997573
13.
The Park Sleep subtype in Parkinson's disease: from concept to clinic.
Expert Opin Pharmacother
; 24(15): 1725-1736, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561080
14.
Hiccups, Hypersalivation, Hallucinations in Parkinson's Disease: New Insights, Mechanisms, Pathophysiology, and Management.
J Pers Med
; 13(5)2023 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240881
15.
Pain in Parkinson disease: mechanistic substrates, main classification systems, and how to make sense out of them.
Pain
; 164(11): 2425-2434, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318012
16.
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience.
Sci Rep
; 13(1): 18681, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907679
17.
Urinary dysfunction in early de novo patients with Parkinson's disease.
Mov Disord
; 32(6): 939-940, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28256013
18.
Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far.
Mov Disord Clin Pract
; 9(5): 584-593, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35601258
19.
Neuroimaging Biomarkers in a Patient with Probable Psychiatric-Onset Prodromal Dementia with Lewy Bodies.
Neurology
; 2022 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953291
20.
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
Int Rev Neurobiol
; 165: 63-89, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208907